Pay in 4 interest-free payments of $7.24 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
The agency has scheduled a Pharmacy Compounding Advisory Committee review for July 2026 to determine whether BPC-157 will be permitted on the 503A bulks list
Potential Side Effects SARMs are not considered safe for human use, as they have not yet received FDA approval and have limited clinical research available
Youre at risk of vitamin B12 deficiency
BPC-157 is studied in in vitro and preclinical research models for tissue repair, gastrointestinal protection, tendon and muscle healing, angiogenesis, nitric-oxide pathway modulation, inflammation control, and neuroprotection-related signaling
As an pro-angiogenic agent, it's theoretically possible for BPC-157 to enable cancers to grow
Lopez A, Tang J, et al
